文献速递重症综合管理与镇静镇痛心脑血管急症

早期危重症恢复期客观与患者报告认知测量的可行性与有效性

The Feasibility and Validity of Objective and Patient-Reported Measurements of Cognition During Early Critical Illness Recovery.
PubMed 文献 · Neurocrit Care · 2020-10-22
一句话结论在神经与全身性危重症早期恢复期,已验证的客观与患者报告认知测评工具不可行或结果无效,疾病持续时间越长、神经认知损害越重,测评可行性越低。

该研究纳入91例社区起病的脑出血(ICH)或脓毒症患者,在ICU出院或出院后7天(以先发生者为准)尝试进行认知评估,包括GCS、三项NIH Toolbox认知测试和两项PROMIS认知测评。因死亡等原因脱落后,73例尝试评估;患者报告结局仅42例(58%)成功获取,且分数异常偏高(中位97百分位),经4名盲法认证神经重症专家分析提示结构效度差;NIH Toolbox仅9例(12%)可完成,均为GCS 15分且完成PROMIS者。ICU住院时间较短与测评成功相关(ICH和脓毒症均p<0.05),ICH评分较低(ICH患者)和无病前痴呆(脓毒症患者)也与成功相关。结论认为,这些在慢性疾病中验证的工具在早期危重症恢复期不可行或结果无效。

要点

  • 患者报告认知测评在早期危重症恢复期仅58%可获取,且分数异常偏高(中位97百分位),结构效度差。
  • NIH Toolbox客观认知测试仅12%患者可完成,完成者均为GCS 15分且已完成PROMIS测评。
  • ICU住院时间较短与测评成功相关(ICH和脓毒症均p<0.05)。
  • ICH评分较低(ICH患者)和无病前痴呆(脓毒症患者)与测评成功相关(均p<0.05)。
  • 疾病持续时间越长、神经认知损害越重(无论慢性或急性),测评可行性越低。

适用人群与场景

  • 社区起病的急性脑出血(ICH)或脓毒症成年患者,作为神经性与全身性危重症的代表人群。
  • 评估时机为ICU出院或出院后7天,以先发生者为准。

研究设计与关键结果

  • 研究为可行性/有效性评估,纳入91例患者(脓毒症53例,ICH 38例),因死亡等脱落后73例尝试认知评估。
  • 脓毒症患者中位SOFA评分7分(IQR 3–11);ICH患者中位ICH评分2分(IQR 1–2),出血部位包括脑叶13例、深部21例、幕下4例。
  • 患者报告结局成功获取42例(总体58%,脓毒症79%,ICH 34%),但分数异常偏高(中位97百分位,对照一般成年人群)。
  • 4名盲法认证神经重症专家分析PROMIS条目库显示,报告症状严重程度越高与条目情境相关性越强(ρ=0.72,p=0.002),提示该人群结构效度差。
  • NIH Toolbox测试仅9例(12%)可完成,均为GCS 15分且完成PROMIS测评者;中位分数5百分位(IQR 2–9百分位),与自报症状不相关。
  • ICU住院时间较短与测评成功相关(ICH和脓毒症均p<0.05);ICH评分较低(ICH患者)和无病前痴呆(脓毒症患者)也与成功相关(均p<0.05)。

证据类型、等级与局限

  • 证据类型:可行性/有效性评估研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在慢性内科和神经疾病中验证的客观与患者报告认知测评工具,在神经与全身性危重症早期恢复期的一般样本中不可行或结果无效。
  • 作者认为,危重症持续时间较长和神经认知损害较重(无论慢性或急性)会降低测评可行性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Cognitive outcomes are an important determinant of quality of life after critical illness, but methods to assess early cognitive impairment and cognition recovery are not established. The objective of this study was to assess the feasibility and validity of objective and patient-reported cognition assessments for generalized use during early recovery from critical illness.

METHODS: Patients presented from the community with acute onset of either intracerebral hemorrhage (ICH) or sepsis as representative neurologic and systemic critical illnesses. Early cognitive assessments comprised the Glasgow Coma Scale (GCS), three NIH Toolbox cognition measures (Flanker Inhibitory Control and Attention Test, List Sorting Working Memory Test and Pattern Comparison Processing Speed Test) and two Patient Reported Outcomes Measurement Information System (PROMIS) cognition measures (Cognition-General Concerns and Cognition-Abilities) performed seven days after intensive care unit discharge or at hospital discharge, whichever occurred first.

RESULTS: We enrolled 91 patients (53 with sepsis, 38 with ICH), and after attrition principally due to deaths, cognitive assessments were attempted in 73 cases. Median [interquartile range] Sequential Organ Failure Assessment scores for patients with sepsis was 7 [3, 11]. ICH cases included 13 lobar, 21 deep and 4 infratentorial hemorrhages with a median [IQR] ICH Score 2 [1, 2]. Patient-reported outcomes were successfully obtained in 42 (58% overall, 79% of sepsis and 34% of ICH) patients but scores were anomalously favorable (median 97th percentile compared to the general adult population). Analysis of the PROMIS item bank by four blinded, board-certified academic neurointensivists revealed a strong correlation between higher severity of reported symptoms and greater situational relevance of the items (ρ = 0.72, p = 0.002 correlation with expert item assessment), indicating poor construct validity in this population. NIH Toolbox tests were obtainable in only 9 (12%) patients, all of whom were unimpaired by GCS (score 15) and completed PROMIS assessments. Median scores were 5th percentile (interquartile range [2nd, 9th] percentile) and uncorrelated with self-reported symptoms. Shorter intensive care unit length of stay was associated with successful testing in both patients with ICH and sepsis, along with lower ICH Score in patients with ICH and absence of premorbid dementia in patients with sepsis (all p < 0.05).

CONCLUSIONS: Methods of objective and patient-reported cognitive testing that have been validated for use in patients with chronic medical and neurologic illness were infeasible or yielded invalid results among a general sample of patients in this study who were in early recovery from neurologic and systemic critical illness. Longer critical illness duration and worse neurocognitive impairments, whether chronic or acute, reduced testing feasibility.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Maas MB, Lizza BD, Kim M, et al. The Feasibility and Validity of Objective and Patient-Reported Measurements of Cognition During Early Critical Illness Recovery. Neurocrit Care. 2020. PMID: 33094468. doi:10.1007/s12028-020-01126-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。